Shades of the Vioxx Case for Another Drug
Interesting dilemma. Right now, they need a prospective study to determine the risks of Bextra – however, it will be several years before the results are in. So, what to do in the meantime? I probably wouldn’t prescribe this in those with cardiac risk factors – we may be going down the same Vioxx path.
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.